MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 35 (7) , 109124
Abstract
No abstract availableKeywords
Funding Information
- AMED
- Japan Society for the Promotion of Science
This publication has 62 references indexed in Scilit:
- Metazoan MicroRNAsCell, 2018
- A Single-Cell RNA Sequencing Study Reveals Cellular and Molecular Dynamics of the Hippocampal Neurogenic NicheCell Reports, 2017
- Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineageMolecular Brain, 2015
- The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturationDevelopmental Neurobiology, 2012
- Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphologyNature Neuroscience, 2009
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- The Story of Rett Syndrome: From Clinic to NeurobiologyNeuron, 2007
- MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse NumberNeuron, 2007
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2Nature Genetics, 1999
- Morphological study of neocortical areas in Rett syndromeActa Neuropathologica, 1997